Intelligent Blood Collection Management Systems Market Global Report 2026

The intelligent blood collection management systems market size has grown strongly in recent years. It will grow from $2.44 billion in 2025 to $2.68 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to inefficiencies in manual paper-based blood tracking systems, high rates of transfusion and labeling errors, increasing demand for safe and reliable blood supply systems, expansion of hospital-based diagnostic laboratory infrastructure, and early adoption of barcode-based identification technologies.

The intelligent blood collection management systems market size is expected to see strong growth in the next few years. It will grow to $3.92 billion in 2030 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to increasing automation in clinical workflows, rising demand for blood driven by surgical procedures and chronic disease prevalence, stricter global regulatory compliance requirements, growing need for real-time blood inventory tracking, and expansion of standardized transfusion safety protocols. Major trends include strengthening of regulatory hemovigilance systems, optimization of cold chain logistics for blood storage, improved interoperability standards across hospital and laboratory systems, consolidation of centralized blood bank networks, and enhanced donor engagement and retention initiatives.

The rising number of blood donation programs is expected to drive the growth of the intelligent blood collection management systems market going forward. Blood donation programs refer to organized initiatives designed to encourage individuals to voluntarily donate blood to support medical treatments, emergency care, and healthcare systems. The increasing number of blood donation programs is driven by rising awareness campaigns, as they motivate more individuals to donate blood regularly to support emergency care and medical treatments. Intelligent blood collection management systems support blood donation programs by streamlining donor registration, scheduling, blood tracking, and inventory management, thereby improving operational efficiency and ensuring timely availability of blood supplies. For instance, in March 2026, according to the American Red Cross, a US-based humanitarian organization, over 25,000 blood donations were collected in the United States through a partnership initiated in 2025, contributing to nearly 40,000 donations. Therefore, the rising number of blood donation programs is driving the growth of the intelligent blood collection management systems market.

Key companies operating in the intelligent blood collection management systems market are focusing on developing advanced automated blood collection technologies, such as autonomous robotic phlebotomy devices, to enhance collection accuracy, improve patient experience, and streamline clinical workflow efficiency. Autonomous robotic phlebotomy devices are automated systems that use robotics, artificial intelligence, and imaging technologies to perform blood collection procedures with minimal human intervention. for example, in March 2025, Vitestro, a Netherlands-based medical robotics company, unveiled Aletta, the world’s first autonomous robotic phlebotomy device. It is designed to support improved blood collection precision and operational efficiency. The system enables automated vein identification, robotic needle insertion, and standardized sample collection, strengthening workflow optimization and patient care in healthcare and diagnostic settings.

In June 2024, Nightingale Health Plc, a Finland-based company specializing in disease risk detection and preventive health solutions, acquired full intellectual property rights associated with the Velvet blood collection device from RenegadeXBio, PBC, for an undisclosed sum. Through this acquisition, Nightingale Health aimed to strengthen its integrated intelligent blood collection management system by moving from a licensing arrangement to full ownership of the Velvet device, enabling complete proprietary control over its remote blood collection and diagnostic workflow. RenegadeXBio, PBC is a US-based biotechnology research organization focused on intelligent blood self-collection technologies and diagnostic systems, including the Velvet device.

Major companies operating in the intelligent blood collection management systems market are Abbott Laboratories, Roche Diagnostics International AG, Becton Dickinson and Company, Fresenius SE & Co. KGaA, Terumo Corporation, Grifols S.A., Haemonetics Corporation, Sysmex Corporation, Sarstedt AG & Co. KG, WellSky Corporation, Macopharma SA, Mak-System, Inpeco, Delcon S.r.l.

North America was the dominant region in the intelligent blood collection management systems market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in intelligent blood collection management systems report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intelligent blood collection management systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intelligent blood collection management systems market consists of revenues earned by entities by providing services such as donor data management, blood inventory tracking, sample identification and barcode labeling, and transfusion workflow monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The intelligent blood collection management systems market also includes sales of blood collection chairs, automated blood collection devices, and portable blood collection carts. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The intelligent blood collection management systems market research report is one of a series of new reports that provides intelligent blood collection management systems market statistics, including intelligent blood collection management systems industry global market size, regional shares, competitors with a intelligent blood collection management systems market share, detailed intelligent blood collection management systems market segments, market trends and opportunities, and any further data you may need to thrive in the intelligent blood collection management systems industry. This intelligent blood collection management systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.